NRX Neuraxis, INC Insider Trading

10% owner Hannasch Brian buys 80,000 shares ($382.8K) at NRX on 2 consecutive days, raising holdings 7.1%

Hannasch Brian executed 2 separate purchases totaling 80,000 shares for $382,800.00 at an average price of $4.78, increasing his stake from 1,131,522 to 1,211,522 shares. The company generated $811,414.00 in latest quarterly revenue but posted a net loss of $-2,122,796.00 and remains unprofitable on a full-year basis, despite annual revenue growth of +9.2%. His cross-ticker track record shows 3 prior buys with an average 90-day return of +3.8%, though his 2 prior purchases at NRX (July 2025 and April 2025) remain too recent to have measurable 90-day outcomes. The consecutive-day execution and 7.1% increase in holdings suggest sustained conviction in the position, though the timing relative to longer-term share price performance is not yet determinable.

Director Aharon Gil buys 286,138 shares of Neuraxis (NRXS) at $3.52 for $1.0M in first personal stock purchase

Aharon Gil, a director, established an initial position of 286,138 shares valued at $1,007,205.76, representing his first open-market purchase in Neuraxis. The transaction occurred at $3.52 per share, and the stock has since risen to $4.20 (at the high end of its 52-week range of $1.60–$4.20), marking a +30.0% move from his entry. Across his cross-ticker trading history, his prior buy transactions averaged +26.2% 30-day returns and +107.8% 90-day returns with a 100.00% 90-day win rate, establishing a materially favorable execution pattern. However, context warrants caution: Neuraxis generated quarterly revenue of only $811,414.00, posted a full-year net income of $-2,122,796.00, and carries a $44,741,810.40 market cap—a company with negative profitability and limited revenue scale. The entry timing relative to current price at the highs, combined with the company's deeply unprofitable fundamentals, presents a contrasting picture to the insider's historical track record.

10% owner Hannasch buys 355,556 shares of NRX for $800,001 at $2.25; holdings rise 45.8% to 1.13M shares

Hannasch Brian, a 10% shareholder in Neuraxis, purchased 355,556 shares ($800,001.00 total) on 2025-07-01, increasing his stake by 45.8% from 775,966 shares to 1,131,522 shares. This represents an open-market buy, but context is mixed: while the purchase is material in absolute dollars and percentage terms, the company is fundamentally challenged with net income of $-2,278,684.00 over its most recent full fiscal year despite 9.2% annual revenue growth ($895,655.00 in the latest quarter). His prior same-ticker buy on 2025-04-21 has no measurable 90-day outcome, and his cross-ticker track record shows only 1 prior open-market buy, limiting any pattern evidence. The significance of a major shareholder continuing to accumulate at this valuation deserves monitoring against the company's operating performance.

10% owner Masimo Corp sold 821,327 shares (821.3K) of NRXS at $2.25 for $1,847,985.75 via 2 transactions

Masimo Corp, a 10% stakeholder in Neuraxis Inc., executed two separate sales totaling 821,327 shares (821.3K shares) for $1,847,985.75 ($1.8M) at $2.25 per share on 2025-07-01. The sale eliminated Masimo's entire shareholding position in NRXS. This transaction occurs against a backdrop of a micro-cap company trading at current prices significantly below its 52-week high (current $2.58 is -35.3% from $3.99 peak) and burning cash, with quarterly revenue of $895,655.00 ($895.7K) against a net loss of $-2,278,684.00 ($-2.3M) and negative full-year net income. While the 90-day price change is +39.5%, the stock has declined -6.9% in 30 days, and the sale was executed at the lower end of recent trading ranges. Note: This filing reflects a derivative conversion; the insider's complete position (including any retained derivative securities per Form 4 Table II) is not yet available in the database and should be verified.

10% Owner Hannasch Brian buys 18,065 shares of NRX at $1.73; stock accrues unprofitable losses while revenue grows 9.2%.

Hannasch Brian, a 10% owner of Neuraxis, purchased 18,065 shares at $1.73 on 2025-04-21, expanding his holdings by 2.4% to 775,966 shares total. The purchase occurs against mixed fundamentals: the company posted +9.2% annual revenue growth but generated a net loss of $1,755,234.00 over its most recent full fiscal year, with the latest quarter showing revenue of only $666,625.00. The acquisition represents a discretionary open-market purchase, but the broader context—unprofitability persisting despite revenue momentum—leaves material operational questions unresolved. Investors should monitor whether the revenue growth trajectory can eventually lead to profitability, or whether the losses remain structural.